Keywords
Last Name
Institution

LOIS M RAMONDETTA

TitleProfessor
InstitutionMD Anderson
DepartmentGynecological Oncology & Reproductive Medicine
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hwang JP, Ahmed S, Ariza-Heredia EJ, Duan Z, Zhao H, Schmeler KM, Ramondetta L, Parker SL, Suarez-Almazor ME, Ferrajoli A, Shih YT, Giordano SH, Chiao EY. Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant. Biol Blood Marrow Transplant. 2018 Feb 09. PMID: 29378304.
      View in: PubMed
    2. Fu S, Shi N, Wheler J, Naing A, Janku F, Piha-Paul S, Gong J, Hong D, Tsimberidou A, Zinner R, Subbiah V, Hou MM, Ramirez P, Ramondetta L, Lu K, Meric-Bernstam F. Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience. Gynecol Oncol Res Pract. 2015; 2:10. PMID: 27231570; PMCID: PMC4880813.
    3. Ramondetta LM, Meyer LA, Schmeler KM, Daheri ME, Gallegos J, Scheurer M, Montealegre JR, Milbourne A, Anderson ML, Sun CC. Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer. Gynecol Oncol. 2015 Dec; 139(3):500-5. PMID: 26498912.
      View in: PubMed
    4. Kim YJ, Munsell MF, Park JC, Meyer LA, Sun CC, Brown AJ, Bodurka DC, Williams JL, Chase DM, Bruera E, Ramondetta LM. Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. Gynecol Oncol. 2015 Dec; 139(3):553-8. PMID: 26432043.
      View in: PubMed
    5. Bradford A, Fellman B, Urbauer D, Gallegos J, Meaders K, Tung C, Ramondetta L. Assessment of sexual activity and dysfunction in medically underserved women with gynecologic cancers. Gynecol Oncol. 2015 Oct; 139(1):134-40. PMID: 26325527.
      View in: PubMed
    6. Watkins JL, Thaker PH, Nick AM, Ramondetta LM, Kumar S, Urbauer DL, Matsuo K, Squires KC, Coleman RL, Lutgendorf SK, Ramirez PT, Sood AK. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer. 2015 Oct 1; 121(19):3444-51. PMID: 26301456.
      View in: PubMed
    7. Montealegre JR, Landgren RM, Anderson ML, Hoxhaj S, Williams S, Robinson DJ, Scheurer ME, Ramondetta LM. Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department. Gynecol Oncol. 2015 Aug; 138(2):317-22. PMID: 26026733.
      View in: PubMed
    8. Brown AJ, Sun CC, Urbauer DL, Bodurka DC, Thaker PH, Ramondetta LM. Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients. Gynecol Oncol. 2015 Aug; 138(2):388-93. PMID: 25988961.
      View in: PubMed
    9. Chase DM, Kauderer J, Wenzel L, Ramondetta L, Cella D, Long HJ, Monk BJ. Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204. Int J Gynecol Cancer. 2015 Feb; 25(2):303-8. PMID: 25405577.
      View in: PubMed
    10. Penson RT, Huang HQ, Wenzel LB, Monk BJ, Stockman S, Long HJ, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Method M, Michael H, Tewari KS. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). Lancet Oncol. 2015 Mar; 16(3):301-11. PMID: 25638326.
      View in: PubMed
    11. Brown AJ, Sun CC, Urbauer D, Zhukovsky DS, Levenback C, Frumovitz M, Thaker PH, Bodurka DC, Ramondetta LM. Targeting those with decreased meaning and peace: a supportive care opportunity. Support Care Cancer. 2015 Jul; 23(7):2025-32. PMID: 25519758; PMCID: PMC4449799 [Available on 07/01/16].
    12. Rycaj K, Plummer JB, Yin B, Li M, Garza J, Radvanyi L, Ramondetta LM, Lin K, Johanning GL, Tang DG, Wang-Johanning F. Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells. Clin Cancer Res. 2015 Jan 15; 21(2):471-83. PMID: 25370465.
      View in: PubMed
    13. Brown AJ, Shen MJ, Ramondetta LM, Bodurka DC, Giuntoli RL, Diaz-Montes T. Does death anxiety affect end-of-life care discussions? Int J Gynecol Cancer. 2014 Oct; 24(8):1521-6. PMID: 25188890.
      View in: PubMed
    14. Brown AJ, Sun CC, Prescott LS, Taylor JS, Ramondetta LM, Bodurka DC. Missed opportunities: Patterns of medical care and hospice utilization among ovarian cancer patients. Gynecol Oncol. 2014 Nov; 135(2):244-8. PMID: 25192878.
      View in: PubMed
    15. Miller DS, Blessing JA, Ramondetta LM, Pham HQ, Tewari KS, Landrum LM, Brown J, Mannel RS. Pemetrexed and cisplatin for the treatment of advanced, persistent, or recurrent carcinoma of the cervix: a limited access phase II trial of the gynecologic oncology group. J Clin Oncol. 2014 Sep 1; 32(25):2744-9. PMID: 25071133.
      View in: PubMed
    16. Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014 Sep; 134(3):546-51. PMID: 25014540; PMCID: PMC4160382.
    17. Sun C, Brown AJ, Jhingran A, Frumovitz M, Ramondetta L, Bodurka DC. Patient preferences for side effects associated with cervical cancer treatment. Int J Gynecol Cancer. 2014 Jul; 24(6):1077-84. PMID: 24905618; PMCID: PMC4287264.
    18. Tewari KS, Sill MW, Long HJ, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, Monk BJ. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014 Feb 20; 370(8):734-43. PMID: 24552320.
      View in: PubMed
    19. Zaid T, Burzawa J, Basen-Engquist K, Bodurka DC, Ramondetta LM, Brown J, Frumovitz M. Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: a feasibility study. Gynecol Oncol. 2014 Jan; 132(1):149-53. PMID: 24145111; PMCID: PMC4265467.
    20. Nagaraja AS, Sadaoui NC, Lutgendorf SK, Ramondetta LM, Sood AK. ß-blockers: a new role in cancer chemotherapy? Expert Opin Investig Drugs. 2013 Nov; 22(11):1359-63. PMID: 23919278.
      View in: PubMed
    21. Ramondetta LM, Sun C, Surbone A, Olver I, Ripamonti C, Konishi T, Baider L, Johnson J. Surprising results regarding MASCC members' beliefs about spiritual care. Support Care Cancer. 2013 Nov; 21(11):2991-8. PMID: 23775154; PMCID: PMC3951207.
    22. Sailors MH, Bodurka DC, Gning I, Ramondetta LM, Williams LA, Mendoza TR, Agarwal S, Sun CC, Cleeland CS. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol. 2013 Aug; 130(2):323-8. PMID: 23685012.
      View in: PubMed
    23. Costales AB, Milbourne AM, Rhodes HE, Munsell MF, Wallbillich JJ, Brown J, Frumovitz M, Ramondetta LM, Schmeler KM. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. Gynecol Oncol. 2013 Jun; 129(3):513-6. PMID: 23541795; PMCID: PMC3822524.
    24. Ramondetta L. What is the appropriate approach to treating women with incurable cervical cancer? J Natl Compr Canc Netw. 2013 Mar 1; 11(3):348-55. PMID: 23486459.
      View in: PubMed
    25. Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol. 2013 May; 129(2):304-9. PMID: 23385150.
      View in: PubMed
    26. Thaker PH, Sood AK, Ramondetta LM. Importance of adrenergic pathways in women's cancers. Cancer Biomark. 2013; 13(3):145-54. PMID: 23912486; PMCID: PMC4144752.
    27. Burzawa J, Schmeler K, Soliman P, Lacour R, Meyer L, Huang M, Bevers M, Frumovitz M, Pustilnik T, Brown J, Anderson M, Ramondetta L, Tortolero-Luna G, Urbauer D, Zhang Q, Broaddus R, Chang S, Gershenson D, Lu K. Evaluation of insulin resistance among endometrial cancer patients. Gynecol Oncol. 2012 Oct; 127(1 Suppl):S8. PMID: 24989595.
      View in: PubMed
    28. Alberts DS, Blessing JA, Landrum LM, Warshal DP, Martin LP, Rose SL, Bonebrake AJ, Ramondetta LM. Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study. Gynecol Oncol. 2012 Dec; 127(3):451-5. PMID: 22986144.
      View in: PubMed
    29. Frumovitz M, Ramirez PT, Macapinlac HA, Klopp AH, Nick AM, Ramondetta LM, Jhingran A. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging. Int J Gynecol Cancer. 2012 Sep; 22(7):1203-7. PMID: 22810967; PMCID: PMC4283482.
    30. Ramondetta L, Zaid TM, Wallace AM. "Doctor, what did I do to deserve this?". Palliat Support Care. 2011 Dec; 9(4):425-7. PMID: 22104419.
      View in: PubMed
    31. Ramondetta LM, Urbauer D, Brown AJ, Richardson G, Thaker PH, Koenig HG, Levenback C, Sun C. Work related stress among gynecologic oncologists. Gynecol Oncol. 2011 Nov; 123(2):365-9. PMID: 21777966.
      View in: PubMed
    32. Seth SG, Goka T, Harbison A, Hollier L, Peterson S, Ramondetta L, Noblin SJ. Exploring the role of religiosity and spirituality in amniocentesis decision-making among Latinas. J Genet Couns. 2011 Dec; 20(6):660-73. PMID: 21695589.
      View in: PubMed
    33. Ramondetta L, Brown A, Richardson G, Urbauer D, Thaker PH, Koenig HG, Gano JB, Sun C. Religious and spiritual beliefs of gynecologic oncologists may influence medical decision making. Int J Gynecol Cancer. 2011 Apr; 21(3):573-81. PMID: 21436706; PMCID: PMC3127444.
    34. Lacour RA, Euscher E, Atkinson EN, Sun CC, Ramirez PT, Coleman RL, Brown J, Gano JB, Burke TW, Ramondetta LM. A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma. Int J Gynecol Cancer. 2011 Apr; 21(3):517-22. PMID: 21436700.
      View in: PubMed
    35. Schlumbrecht MP, Gallagher CM, Sun CC, Ramondetta LM, Bodurka DC. Ethics consultation on a gynecologic oncology service: an opportunity for physician education. J Cancer Educ. 2011 Mar; 26(1):183-7. PMID: 20835927.
      View in: PubMed
    36. Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer. Pharmacotherapy. 2011 Mar; 31(3):280-97. PMID: 21361739.
      View in: PubMed
    37. Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM, Tortolero-Luna G, Urbauer DL, Chang S, Gershenson DM, Brown J, Lu KH. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol. 2011 Apr; 204(4):355.e1-7. PMID: 21324431; PMCID: PMC4286377.
    38. Kincey J, Westin SN, Zhao B, Curtis MG, Ramondetta L. Surgical removal of a gigantic abdominal mass: a multidisciplinary approach. Obstet Gynecol. 2011 Feb; 117(2 Pt 2):508-12. PMID: 21252807.
      View in: PubMed
    39. Shen Q, Stanton ML, Feng W, Rodriguez ME, Ramondetta L, Chen L, Brown RE, Duan X. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma. Int J Clin Exp Pathol. 2010; 4(1):13-21. PMID: 21228924.
      View in: PubMed
    40. Ramirez PT, Jhingran A, Macapinlac HA, Euscher ED, Munsell MF, Coleman RL, Soliman PT, Schmeler KM, Frumovitz M, Ramondetta LM. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer. 2011 May 1; 117(9):1928-34. PMID: 21509770; PMCID: PMC4286384.
    41. Clements A, Euscher E, Lacour R, Merritt W, Klopp A, Ramondetta L. The presence of human papillomavirus or p16 in six cases of retroperitoneal carcinoma. Obstet Gynecol. 2010 Nov; 116(5):1042-6. PMID: 20966687.
      View in: PubMed
    42. Brown J, Smith JA, Ramondetta LM, Sood AK, Ramirez PT, Coleman RL, Levenback CF, Munsell MF, Jung M, Wolf JK. Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial. Cancer. 2010 Nov 1; 116(21):4973-9. PMID: 20665499.
      View in: PubMed
    43. Palos GR, Mendoza TR, Liao KP, Anderson KO, Garcia-Gonzalez A, Hahn K, Nazario A, Ramondetta LM, Valero V, Lynch GR, Jibaja-Weiss ML, Cleeland CS. Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer. 2011 Mar 1; 117(5):1070-9. PMID: 20960510; PMCID: PMC3065823.
    44. Cella D, Huang HQ, Monk BJ, Wenzel L, Benda J, McMeekin DS, Cohn D, Ramondetta L, Boardman CH. Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Dec; 119(3):531-7. PMID: 20837359; PMCID: PMC4687012.
    45. Zand B, Euscher ED, Soliman PT, Schmeler KM, Coleman RL, Frumovitz M, Jhingran A, Ramondetta LM, Ramirez PT. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol. 2010 Dec; 119(3):422-5. PMID: 20837355; PMCID: PMC4286254.
    46. Soliman PT, Frumovitz M, Spannuth W, Greer MJ, Sharma S, Schmeler KM, Ramirez PT, Levenback CF, Ramondetta LM. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010 Nov; 119(2):291-4. PMID: 20708226; PMCID: PMC4264592.
    47. Slomovitz BM, Lu KH, Johnston T, Coleman RL, Munsell M, Broaddus RR, Walker C, Ramondetta LM, Burke TW, Gershenson DM, Wolf J. A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma. Cancer. 2010 Dec 1; 116(23):5415-9. PMID: 20681032.
      View in: PubMed
    48. Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, Benda J, Cella D. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2009 Oct 1; 27(28):4649-55. PMID: 19720909.
      View in: PubMed
    49. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter? Int J Gynecol Cancer. 2009 Aug; 19(6):1107-12. PMID: 19820377.
      View in: PubMed
    50. Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol. 2009 Oct; 115(1):6-11. PMID: 19632709.
      View in: PubMed
    51. Ramondetta LM, Johnson AJ, Sun CC, Atkinson N, Smith JA, Jung MS, Broaddus R, Iyer RB, Burke T. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 2009 May 1; 115(9):1867-74. PMID: 19241422.
      View in: PubMed
    52. Coker AL, Eggleston KS, Du XL, Ramondetta L. Ethnic disparities in cervical cancer survival among Medicare eligible women in a multiethnic population. Int J Gynecol Cancer. 2009 Jan; 19(1):13-20. PMID: 19258935.
      View in: PubMed
    53. Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L, Hughes D, Carmack Taylor C. Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol. 2009 Mar; 200(3):288.e1-8. PMID: 19110220.
      View in: PubMed
    54. Gaikwad A, Wolf JK, Brown J, Ramondetta LM, Smith JA. In vitro evaluation of the effects of gefitinib on the cytotoxic activity of selected anticancer agents in a panel of human endometrial cancer cell lines. J Oncol Pharm Pract. 2009 Mar; 15(1):35-44. PMID: 18753181.
      View in: PubMed
    55. Westin SN, Bustillos D, Gano JB, Fields MM, Coker AL, Sun CC, Ramondetta LM. Social factors affecting treatment of cervical cancer: ethical issues and policy implications. Obstet Gynecol. 2008 Mar; 111(3):747-51. PMID: 18310380.
      View in: PubMed
    56. Jones KL, Saucier JM, Sun CC, Bevers MW, Ramondetta LM, Brown J, Smith JA. Comparison of chemotherapy education and patient preferences in community versus academic gynecology oncology clinics. J Oncol Pharm Pract. 2008 Mar; 14(1):31-6. PMID: 18337438.
      View in: PubMed
    57. Navo MA, Smith JA, Gaikwad A, Burke T, Brown J, Ramondetta LM. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Cancer Chemother Pharmacol. 2008 Aug; 62(3):483-9. PMID: 18004570.
      View in: PubMed
    58. Ramondetta LM, Jhingran A. Eleven years: the long and winding road. Gynecol Oncol. 2007 Nov; 107(2):166-8. PMID: 17950382.
      View in: PubMed
    59. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys. 2008 Jan 1; 70(1):118-25. PMID: 17869451.
      View in: PubMed
    60. Smith JA, Gaikwad A, Yu J, Wolf JK, Brown J, Ramondetta LM, Stewart CF. In vitro evaluation of the effects of gefitinib on the modulation of cytotoxic activity of selected anticancer agents in a panel of human ovarian cancer cell lines. Cancer Chemother Pharmacol. 2008 Jun; 62(1):51-8. PMID: 17849119.
      View in: PubMed
    61. Slieper CF, Wasson K, Ramondetta LM. From technician to professional: integrating spirituality into medical practice. Am J Bioeth. 2007 Jul; 7(7):26-7. PMID: 17654378.
      View in: PubMed
    62. Lin YG, Deavers M, Sasan F, Zager JS, Ramondetta LM. Clinical challenges presented by three simultaneous solid tumors. Gynecol Oncol. 2006 Dec; 103(3):1159-63. PMID: 17055558.
      View in: PubMed
    63. Pothuri B, Ramondetta L, Eifel P, Deavers MT, Wilton A, Alektiar K, Barakat R, Soslow RA. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers. Gynecol Oncol. 2006 Dec; 103(3):948-51. PMID: 16870239.
      View in: PubMed
    64. Ramondetta LM, Sun C, Hollier L, Jarrett L, Folloder J, Tortolero-Luna G, Hughes A, Jhingran A, Brown J. Advanced cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy. Gynecol Oncol. 2006 Nov; 103(2):547-53. PMID: 16730784.
      View in: PubMed
    65. Smith JA, Gaikwad A, Ramondetta LM, Wolf JK, Brown J. Determination of the mechanism of gemcitabine modulation of cisplatin drug resistance in panel of human endometrial cancer cell lines. Gynecol Oncol. 2006 Nov; 103(2):518-22. PMID: 16690105.
      View in: PubMed
    66. Canada AL, Parker PA, Basen-Engquist K, de Moor JS, Ramondetta LM. Active coping mediates the association between religion/spirituality and functional well-being in ovarian cancer. Gynecol Oncol. 2005 Dec; 99(3 Suppl 1):S125. PMID: 16450431.
      View in: PubMed
    67. Canada AL, Parker PA, de Moor JS, Basen-Engquist K, Ramondetta LM, Cohen L. Active coping mediates the association between religion/spirituality and quality of life in ovarian cancer. Gynecol Oncol. 2006 Apr; 101(1):102-7. PMID: 16256181.
      View in: PubMed
    68. Stevens TA, Brown J, Zander DS, Bevers MW, Gershenson DM, Ramondetta LM. Adult granulosa cell tumors of the ovary in two first-degree relatives. Gynecol Oncol. 2005 Sep; 98(3):502-5. PMID: 15992917.
      View in: PubMed
    69. Lee CM, Slomovitz BM, Greer M, Sharma S, Gregurich MA, Burke T, Lu KH, Ramondetta LM. Practice patterns of SGO members for stage IIIA endometrial cancer. Gynecol Oncol. 2005 Jul; 98(1):77-83. PMID: 15907988.
      View in: PubMed
    70. Jenkins AD, Ramondetta LM, Sun C, Johnston T, Wolf JK, Bodurka DC, Brown J, Atkinson EN, Levenback C. Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 2005 Jun; 97(3):840-4. PMID: 15882895.
      View in: PubMed
    71. Caudell JJ, Deavers MT, Slomovitz BM, Lu KH, Broaddus RR, Gershenson DM, Ramondetta LM. Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas. Appl Immunohistochem Mol Morphol. 2005 Jun; 13(2):167-70. PMID: 15894930.
      View in: PubMed
    72. Orejuela FJ, Ramondetta LM, Smith J, Brown J, Lemos LB, Li Y, Hollier LM. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Gynecol Oncol. 2005 May; 97(2):483-8. PMID: 15863148.
      View in: PubMed
    73. Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, Gershenson DM. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol. 2005 May; 97(2):489-96. PMID: 15863149.
      View in: PubMed
    74. Slomovitz BM, Ramondetta LM, Lee CM, Oh JC, Eifel PJ, Jhingran A, Burke TW, Gershenson DM, Lu KH. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int J Gynecol Cancer. 2005 May-Jun; 15(3):510-6. PMID: 15882178.
      View in: PubMed
    75. Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma. Gynecol Oncol. 2004 Oct; 95(1):32-6. PMID: 15385107.
      View in: PubMed
    76. Wolf JK, Bodurka DC, Gano JB, Deavers M, Ramondetta L, Ramirez PT, Levenback C, Gershenson DM. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. Gynecol Oncol. 2004 Aug; 94(2):442-8. PMID: 15297186.
      View in: PubMed
    77. Ramondetta LM, Tortolero-Luna G, Bodurka DC, Sills D, Basen-Engquist K, Gano J, Levenback C. Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study. Int J Gynecol Cancer. 2004 Jul-Aug; 14(4):580-8. PMID: 15304150.
      View in: PubMed
    78. Amant F, Vergote I. Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma. Gynecol Oncol. 2004 Apr; 93(1):272-3; author reply 273-4. PMID: 15047252.
      View in: PubMed
    79. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys. 2004 Mar 1; 58(3):786-96. PMID: 14967435.
      View in: PubMed
    80. Ramondetta LM, Sills D. Spirituality in gynecological oncology: a review. Int J Gynecol Cancer. 2004 Mar-Apr; 14(2):183-201. PMID: 15086714.
      View in: PubMed
    81. Smith JA, Brown J, Martin MC, Ramondetta LM, Wolf JK. An in vitro study of the inhibitory activity of gemcitabine and platinum agents in human endometrial carcinoma cell lines. Gynecol Oncol. 2004 Jan; 92(1):314-9. PMID: 14751176.
      View in: PubMed
    82. Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol. 2003 Dec; 91(3):463-9. PMID: 14675663.
      View in: PubMed
    83. Ramondetta LM, Sills D. Spirituality and religion in the "art of dying". J Clin Oncol. 2003 Dec 1; 21(23):4460-2. PMID: 14645439.
      View in: PubMed
    84. Shvartsman HS, Langstein H, Worley C, Malpica A, Ramondetta LM. Use of a vacuum-assisted closure device in the treatment of recurrent Paget's disease of the vulva. Obstet Gynecol. 2003 Nov; 102(5 Pt 2):1163-6. PMID: 14607043.
      View in: PubMed
    85. Ramondetta LM, Burke TW, Jhingran A, Schmandt R, Bevers MW, Wolf JK, Levenback CF, Broaddus R. A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36. PMID: 13678720.
      View in: PubMed
    86. Pothuri B, Ramondetta L, Martino M, Alektiar K, Eifel PJ, Deavers MT, Venkatraman E, Soslow RA, Barakat RR. Development of endometrial cancer after radiation treatment for cervical carcinoma. Obstet Gynecol. 2003 May; 101(5 Pt 1):941-5. PMID: 12738155.
      View in: PubMed
    87. Ramondetta LM, Bodurka DC, Tortolero-Luna G, Gordinier M, Wolf JK, Gershenson DM, Sciscione AC. Mentorship and productivity among gynecologic oncology fellows. J Cancer Educ. 2003; 18(1):15-9. PMID: 12825629.
      View in: PubMed
    88. Holtz D, Ramondetta LM, Burke TW, Palazzo JP, Dunton CJ, Atkinson EN, Broaddus RR. PTEN expression in tamoxifen-associated endometrial cancers. Anticancer Res. 2002 Sep-Oct; 22(5):2945-8. PMID: 12530022.
      View in: PubMed
    89. Ramondetta LM, Silva EG, Levenback CF, Burke TW. Mixed choriocarcinoma in a postmenopausal patient. Int J Gynecol Cancer. 2002 May-Jun; 12(3):312-6. PMID: 12060455.
      View in: PubMed
    90. Ramirez PT, Gershenson DM, Tortolero-Luna G, Ramondetta LM, Fightmaster D, Wharton JT, Wolf JK. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Gynecol Oncol. 2001 Dec; 83(3):543-8. PMID: 11733969.
      View in: PubMed
    91. Ramirez PT, Ramondetta LM, Burke TW, Gershenson DM, Brewer MA. Metastatic uterine papillary serous carcinoma to the pericardium. Gynecol Oncol. 2001 Oct; 83(1):135-7. PMID: 11585425.
      View in: PubMed
    92. Ramondetta L, Burke TW, Levenback C, Bevers M, Bodurka-Bevers D, Gershenson DM. Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol. 2001 Jul; 82(1):156-61. PMID: 11426978.
      View in: PubMed
    93. Gordinier ME, Ramondetta LM, Parker LP, Wolf JK, Follen M, Gershenson DM, Bodurka-Bevers D. Survey of female gynecologic oncologists and fellows: balancing professional and personal life. Gynecol Oncol. 2000 Nov; 79(2):309-14. PMID: 11063663.
      View in: PubMed
    94. Ramondetta L, Mills GB, Burke TW, Wolf JK. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Clin Cancer Res. 2000 Jan; 6(1):278-84. PMID: 10656459.
      View in: PubMed
    95. Ramondetta LM, Sherwood JB, Dunton CJ, Palazzo JP. Endometrial cancer in polyps associated with tamoxifen use. Am J Obstet Gynecol. 1999 Feb; 180(2 Pt 1):340-1. PMID: 9988797.
      View in: PubMed
    96. Ramondetta LM, Palazzo JP, Dunton CJ, Kovatich AJ, Carlson JA. A comparative analysis of Ki-67, p53, and p21WAF1CIP1 expression in tamoxifen associated endometrial carcinomas. Anticancer Res. 1998 Nov-Dec; 18(6B):4661-5. PMID: 9891537.
      View in: PubMed
    97. Ramondetta LM, Carlson JA, Schwarting R. Atypical Meigs' syndrome and bilateral ovarian stromal hyperplasia. A case report. J Reprod Med. 1997 Sep; 42(9):603-5. PMID: 9336761.
      View in: PubMed
    98. van Hoeven KH, Ramondetta L, Kovatich AJ, Bibbo M, Dunton CJ. Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions. Int J Gynecol Pathol. 1997 Jan; 16(1):15-21. PMID: 8986527.
      View in: PubMed
    99. Ramondetta LM, Dunton CJ, Shapiro MJ, Carlson JA, Arsuaga J. Percutaneous abscess drainage in gynecologic cancer patients. Gynecol Oncol. 1996 Sep; 62(3):366-9. PMID: 8812534.
      View in: PubMed
    100. Clinical report - Maternal-fetal intervention and fetal care centers. Pediatrics. 128.
    101. Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer. Gynecologic Oncology. 143:466-471.
    102. Controversies in Endometrial Cancer Screening and Diagnosis. 241-247.
    103. Room for improvement. Gynecologic Oncology. 142:525-530.
    104. Dying well. Gynecologic Oncology.
    105. Node-positive adenocarcinoma of the endometrium. Obstetrical and Gynecological Survey. 64:798-800.
    106. Association between Vaginal Douching and Genital Human Papillomavirus Infection among Women in the United States. Journal of Infectious Diseases. 214:1370-1375.
    107. Improved survival with bevacizumab in advanced cervical cancer. Obstetrical and Gynecological Survey. 69:331-332.
    108. End-of-life care for elderly patients with gynecologic cancer. 367-390.
    109. Survival of patients with metastatic leiomyosarcoma. Cancer Medicine. 5:3437-3444.
    110. Human Papillomavirus Vaccine Uptake in Texas Pediatric Care Settings. Journal of Community Health. 1-8.
    111. Improved survival with bevacizumab in advanced cervical cancer. New England Journal of Medicine. 370:734-743.
    112. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer. 121:3444-3451.
    113. A pilot study of laparoscopic extraperitoneal lymph node dissection in patients with locally advanced cervical cancer. Clinical Ovarian Cancer. 3:113-117.
    114. In reply. Obstetrics and Gynecology. 118:710-711.
    RAMONDETTA's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description